Related Experiment Video
Updated: Jan 4, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Inhibition of cyclin-dependent kinase 5 activity alleviates diabetes-related cognitive deficits
Abstract:
Cognitive deficit is a prevalent and underestimated complication of diabetes, and the underlying cellular and molecular mechanisms are not well understood. Aberrant activity of cyclin-dependent kinase (Cdk)5 is implicated in a number of neurodegenerative diseases. The present study examined the role of Cdk5 in the progression of diabetes-related cognitive deficits. We showed that the Cdk5 protein expression and kinase activity were significantly increased in diabetic mice at 16 wk. In primary cultured hippocampal neurons exposed to 30 mM glucose, Cdk5 protein and kinase activity were also elevated in a time-dependent manner. Moreover, the high glucose exposure led to an aberrant Cdk5 activation due to its activator p25 that was cleaved from p35 by calpain. Both in diabetic mice and in cultured hippocampal neurons exposed to high glucose, inhibition of Cdk5 activity with roscovitine (Ros) or short hairpin RNA (shRNA) decreased the protein levels of cleaved caspase-3 and the ratio of Bax and Bcl-2. The apoptotic rate detected by TUNEL in vivo or Annexin V and propidium iodide staining for flow cytometry in vitro also had obvious reduction. In addition, high glucose exposure resulted in the increase of phosphorylated (phospho)-MAPK kinase (MKK)6, phospho-p38, and c-Jun, which were rescued by Ros or Cdk5 shRNA. It is more important that the cognitive deficits of diabetic mice were also effectively alleviated by Ros. These results indicate that aberrant Cdk5 activity triggered hippocampal neuron apoptosis by activating MKK6/p38 MAPK cascade in hyperglycemia. Inhibition of Cdk5 overactivation attenuates neuronal apoptosis and cognitive deficits and contributes to the relief of diabetic neurotoxicity in the brain.-Liu, W., Zhou, Y., Liang, R., Zhang, Y. Inhibition of cyclin-dependent kinase 5 activity alleviates diabetes-related cognitive deficits.
Insights
Diabetic cognitive deficits are linked to increased cyclin-dependent kinase 5 (Cdk5) activity. Inhibiting Cdk5 reduces neuronal apoptosis and improves cognitive function in diabetic mice, offering a potential therapeutic target.
Area of Science:
- Neuroscience
- Endocrinology
- Molecular Biology
Background:
- Diabetes mellitus is associated with cognitive deficits, but underlying mechanisms remain unclear.
- Aberrant cyclin-dependent kinase 5 (Cdk5) activity is implicated in neurodegenerative diseases.
- The role of Cdk5 in diabetes-related cognitive impairment requires further investigation.
Purpose of the Study:
- To investigate the role of Cdk5 in the development of cognitive deficits in diabetes.
- To explore the molecular mechanisms by which Cdk5 contributes to neuronal damage in hyperglycemia.
- To evaluate the therapeutic potential of inhibiting Cdk5 activity in diabetic cognitive impairment.
Main Methods:
- Diabetic mouse model and primary cultured hippocampal neurons exposed to high glucose.
- Assessment of Cdk5 protein expression, kinase activity, and activation by its cofactor p25.
- Inhibition of Cdk5 using roscovitine (Ros) or short hairpin RNA (shRNA).
- Evaluation of apoptosis markers (caspase-3, Bax/Bcl-2 ratio, TUNEL, Annexin V/propidium iodide staining).
- Analysis of the MKK6/p38 MAPK signaling pathway.
- Behavioral testing to assess cognitive function in diabetic mice.
Main Results:
- Cdk5 protein expression and kinase activity were significantly elevated in diabetic mice and high glucose-treated neurons.
- High glucose induced aberrant Cdk5 activation via p25 cleavage by calpain.
- Cdk5 inhibition reduced neuronal apoptosis by decreasing cleaved caspase-3 and altering Bax/Bcl-2 ratio.
- Cdk5 inhibition attenuated the activation of the MKK6/p38 MAPK pathway.
- Treatment with roscovitine significantly alleviated cognitive deficits in diabetic mice.
Conclusions:
- Aberrant Cdk5 activity in hyperglycemia promotes hippocampal neuron apoptosis through the MKK6/p38 MAPK cascade.
- Inhibition of Cdk5 overactivation mitigates neuronal apoptosis and cognitive deficits.
- Targeting Cdk5 offers a promising strategy for treating diabetic neurotoxicity and cognitive impairment.
More Related Videos
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
Related Concept Videos
Inhibition of Cdk Activity
Psychoneuroimmunology: Diabetes and Cancer
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Positive Regulator Molecules
Anaphase Promoting Complex
Dipeptidyl Peptidase 4 Inhibitors